Eiko Lifesciences Ltd Quarterly Results

Gross Sales

7.49

8.16

10.75

0.84

0.56

Excise Duty

0

0

0

0

0

Net Sales

7.49

8.16

10.75

0.84

0.56

Other Operating Income

0

0

0

0

0

Other Income

0.09

0.13

0.26

0.01

0.05

Total Income

7.58

8.29

11.01

0.85

0.61

Total Expenditure

6.85

7.73

10.36

0.89

0.42

PBIDT

0.73

0.55

0.66

-0.03

0.18

Interest

0.03

0.04

0.03

0.1

0.01

PBDT

0.7

0.52

0.63

-0.14

0.18

Depreciation

0.16

0.16

0.17

0.04

0.04

Minority Interest Before NP

0

0

0

0

0

Tax

0.11

0.07

0.09

0.01

0.01

Deferred Tax

0.03

0.03

0.03

-0.05

0.03

Reported Profit After Tax

0.4

0.26

0.35

-0.13

0.1

Minority Interest After NP

0.01

0

0

-0.08

0.04

Net Profit after Minority Interest

0.41

0.28

0.37

-0.05

0.06

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

0.41

0.28

0.37

-0.05

0.06

EPS (Unit Curr.)

0.32

0.22

0.29

-0.14

0.17

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

12.87

12.87

12.87

3.82

3.82

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

9.74

6.74

6.13

-3.57

32.14

PBDTM(%)

9.34

6.37

5.86

-16.66

32.14

PATM(%)

5.34

3.18

3.25

-15.47

17.85